However, the company’s operating loss of $2.28 million was also an increase of 11.5 percent compared to 2012’s third quarter. The company’s operating expenses increased from $3.48 million in 2012 to $4.58 million in 2013.
More Articles on Devices:
NuVasive Q3 Income at $7k, Up Nearly 250% From Last Year
ArthroCare Profits Increase 4.27% in Q3
Device Companies — 7 Key Notes — Zimmer, Boston Scientific & More
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
